Keyword: Mayzent (siponimod)

Ocrevus

3. Ocrevus

Multiple sclerosis drug Ocrevus is hailed as the most successful launch in Roche’s history, earning blockbuster status in its first 12 months.
Novartis

4. Novartis

Novartis kept things busy in 2019 as it continued to focus on becoming a top medicines company. It spun off eye care medtech business Alcon, and at the same time bought legacy Shire’s Xiidra to boost its ophthalmic drug franchise and acquired The Medicines Company for cholesterol-lowering med inclisiran.